Chile’s leprosy milestone still required care

Historical report — WHO verified Chile’s elimination of leprosy on March 4, 2026. The agency reported 47 diagnoses during 2012–2023, none locally acquired. Its account paired the absence of locally acquired disease with continuing clinical training and referrals. ^[1]

WHO’s 2023 framework distinguishes interruption of transmission, elimination of disease and post-elimination surveillance. It allows for sporadic diagnoses during the last phase because leprosy has a long incubation period. That sequence explains why a country can earn recognition while retaining the capacity to identify and manage cases. A declaration and a functioning surveillance service answer different questions about progress. ^[2]

The medical explanation also matters for everyday treatment of people. WHO’s January 2026 factsheet says transmission involves prolonged, close contact with untreated cases; handshakes, hugs and shared meals do not spread the disease. It describes leprosy as curable and says early treatment can prevent disability. Those facts undercut treating a diagnosis as a reason for ordinary social exclusion. ^[3]

In June 2008, the UN Human Rights Council affirmed the dignity and rights of people affected by leprosy and their families, and called for measures against discrimination. That standard concerns treatment of people independently of case totals. The resolution is not evidence that Chile’s verification measured or eliminated discrimination. ^[4]

About this item: Retrospective report. No first-hand reporting or independent testing is claimed. Corrections policy.